Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C

Background Chronic hepatitis C is associated with significant morbidity and mortality as a consequence of progression to cirrhosis, hepatocellular carcinoma, and liver failure. Current treatment for chronic hepatitis C with pegylated interferon (IFN) and ribavirin is associated with suboptimal respo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Reddy, K Rajender, Belle, Steven H, Fried, Michael W, Afdhal, Nezam, Navarro, Victor J, Hawke, Roy L, Wahed, Abdus S, Doo, Edward, Meyers, Catherine M
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2012
Teme:
Design
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3293174/
https://ncbi.nlm.nih.gov/pubmed/22058086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774511427064
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items